The culture of emphasis on innovation, quality, and speed will remain and be nourished, To transcend the Immuno-Oncology therapeutics by developing cutting-edge designer biologics with innovative modalities for cancer patients.
Investors 2
| Date | Name | Website |
| 12.01.2023 | Korea Inve... | partners.k... |
| - | Panacea Ve... | panaceaven... |